Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
Schmidt, B; Schimpl, G; Höllwarth, ME.
OK-432 therapy of lymphangiomas in children.
EUR J PEDIAT 1996 155: 649-652.
Doi: 10.1007%2Fs004310050460
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Schmidt Barbara
- Co-Autor*innen der Med Uni Graz
- Höllwarth Michael
- Schimpl Guenther
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Between April 1988 and July 1995, 11 children with lymphangioma were treated with intralesional OK-432 injection. In 7 patients it was the primary therapy and total shrinkage of the lesion was obtained in 5 of them. Two patients did not respond and the children underwent surgery. Following incomplete surgical removal or recurrence of the lymphangioma, intralesional OK-432 injection was used as secondary therapy in 4 patients. Total regression was observed in 2 cases and marked regression in the 2 others. No serious side-effects except fever lasting for 2-3 days and slight tenderness with swelling of the lymphangioma for 3-4 days after the injection was noted. Local inflammatory reaction did not cause any damage to the overlying skin and did not lead to scar formation. Depending on the size, location, and anatomical relationship of the airway, intralesional injections of the lymphangiomas were performed under general anaesthesia and the children were observed for 24 h. There was no recurrence after follow up periods ranging from 2 months to 7 years. CONCLUSION: Intralesional injection OK-432 represents an alternative, safe and effective treatment for lymphangiomas. It can be used as the primary therapy, after partial surgical excision, or in recurrent lymphangiomas.
- Find related publications in this database (using NLM MeSH Indexing)
- Antineoplastic Agents - administration and dosage
- Child - administration and dosage
- Child, Preschool - administration and dosage
- Facial Neoplasms - drug therapy
- Female - drug therapy
- Follow-Up Studies - drug therapy
- Head and Neck Neoplasms - drug therapy
- Humans - drug therapy
- Infant - drug therapy
- Lymphangioma - drug therapy
- Neoplasm Recurrence, Local - surgery
- Picibanil - administration and dosage
- Sclerosing Solutions - administration and dosage
- Thoracic Neoplasms - drug therapy
- Find related publications in this database (Keywords)
- Lymphangioma
- Sclerosing Therapy
- OK-432